Perspective Therapeutics (CATX) Preferred Shares (2011 - 2014)
Perspective Therapeutics (CATX) reported Preferred Shares of $59.0 for Q2 2014, little changed on a YoY basis from $59.0 in Q2 2013, and little changed sequentially from $59.0 in Q1 2014.
Perspective Therapeutics (CATX) Preferred Shares (2011 - 2014) Analysis & Trends
Perspective Therapeutics (CATX) has 4 years of Preferred Shares data on file, last reported at $59.0 in Q2 2014.
- For the quarter ending Q2 2014, Preferred Shares changed 0.0% year-over-year to $59.0; the trailing twelve-month figure through Jun 2014 stood at $59.0 (changed 0.0% YoY), and the FY2014 full-year result was $59.0, changed 0.0% from the prior year.
- Preferred Shares was little changed at $59.0 in Q2 2014, from $59.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $61.0 in Q3 2013 to a low of $59.0 in Q2 2011.
- A 4-year average of $59.31 and a median of $59.0 in 2011 frame the typical range for Preferred Shares.
- Across the five-year window, Preferred Shares changed 0.0% in 2012 and advanced 3.39% in 2013, its largest moves.
- Tracing CATX's Preferred Shares over 4 years: stood at $59.0 in 2011, then changed by 0.0% to $59.0 in 2012, then climbed by 3.39% to $61.0 in 2013, then fell by 3.28% to $59.0 in 2014.
- Business Quant data shows CATX's Preferred Shares at $59.0 in Q2 2014, $59.0 in Q1 2014, and $61.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 59.00 |
| Mar 31, 2014 | 59.00 |
| Dec 31, 2013 | 61.00 |
| Sep 30, 2013 | 61.00 |
| Jun 30, 2013 | 59.00 |
| Mar 31, 2013 | 59.00 |
| Dec 31, 2012 | 59.00 |
| Sep 30, 2012 | 59.00 |
| Jun 30, 2012 | 59.00 |
| Mar 31, 2012 | 59.00 |
| Dec 31, 2011 | 59.00 |
| Sep 30, 2011 | 59.00 |
| Jun 30, 2011 | 59.00 |